CVS Health Profit Rises 34% On Vaccine, Test Boost
(Reuters) -CVS Health Corp’s quarterly profit rose 34.2% on Wednesday, helped by Omicron-spurred demand for COVID-19 tests and vaccinations. The company administered over 8 million COVID-19 tests and more than 20 million coronavirus vaccines across the U.S. during the quarter, CVS said. Net income attributable to the company’s shareholders rose to $1.31 billion, or 98…